• Home
  • About
    • Psychedelic For Healthy People
    • Psilocybin (Magic Mushrooms)
    • Ayahuasca (Chacruna – Kaapi – Yajé)
    • MDMA (MDA – Sassafras)
    • Peyote Mescaline (Huachuma)
    • Kambo – Amazonian Frog
    • 5-MeO-DMT (Toad Medicine)
    • Rapé And Sacred Tobacco
    • Iboga (Ibogaine)
    • LSD (Lysergic Acid Diethylamide)
    • Cannabis (Marijuana)
    • Ketamine
    • Psychedelic Integration
    • Psychedelics Advocates
    • Frequently Asked Questions
    • Mental Health Symptoms
    • Substances Test Kits
    • Manifesto
  • Treatments
    • Latest Psychedelic Research
    • Addiction
    • Alcoholism
    • Anxiety
    • Bipolar Disorder
    • Cancer
    • Cluster Headaches
    • Depression
    • End Of Life
    • OCD
    • Neuropathy
    • Pain
    • Parkinson’s Disease
    • PTSD
    • Smoking
    • Help Treat Mental Illness
  • Microdosing
    • What is Microdosing?
    • Microdosing Magic Mushrooms
    • Microdosing LSD
    • Microdosing MDMA
    • Microdosing Ayahuasca
    • Microdosing Mescaline
    • Microdosing Cannabis
    • Microdosing Ibogaine
  • Resources
    • Past Events
    • ALL Locations
    • DMT Psychoactive Plants
    • Medical Trials And Research
    • Psychedelic Research
    • EntheoPodcasts
    • In The News
    • Books On Psychedelics
    • Related Videos
    • EntheoResources
    • Terence McKenna
    • What Is Psychedelic Art?
    • Useful Links
    • Movies & Documentaries
    • Michael Pollan
Contact
  • Follow
  • Follow
  • Follow
  • Follow
Psychedelic treatment: New psilocybin mushroom protocol

Psychedelic treatment: New psilocybin mushroom protocol

by EmpathiCSubstanceS | Nov 9, 2021 | Addiction, Alcoholism, Chronic Pain, Depression, Microdosing, NN-Dimethyltryptamine

In a small study of adults with major depression, Johns Hopkins Medicine researchers report that two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms, with most participants...
Psychedelic treatment: New psilocybin mushroom protocol

What Happens When Blind People Take Psychedelics?

by EmpathiCSubstanceS | Nov 9, 2021 | Addiction, Alcoholism, Iboga, MDMA Sassafras Molly

Earlier this month, a student from Singapore tripping on shrooms in a Bali hotel jumped five floors to his death. The news recalled an incident from a year ago, when a 23-year old banker at Merrill Lynch had plunged 26 stories after eating some magic mushrooms. These...
Psychedelic treatment: New psilocybin mushroom protocol

Do Psychedelics Just Provide Comforting Delusions?

by EmpathiCSubstanceS | Nov 8, 2021 | Addiction, Alcoholism, Ayahuasca, Cancer, Cluster Headaches, Depression, Iboga, Kambo, Parkinson's Disease, Psychotropics

And if so, does it matter? In a new book, philosopher Chris Letheby confronts the nature and implications of the mystical experiences people often have while taking psychedelics. There’s an “elephant in the room” of psychedelic science, according to an opinion...
Psychedelic treatment: New psilocybin mushroom protocol

How Long Does DMT Stay In Your System?

by EmpathiCSubstanceS | Nov 8, 2021 | Addiction, Bipolar Disorder, Chronic Pain, Depression, MDMA Sassafras Molly, Neuropathy, Pain, PTSD

DMT (N, N-Dimethyltryptamine) is an endogenous hallucinogen or drug, which means it’s a substance that’s common in living organisms like plants and can cause mind-altering side effects. Because DMT drug effects are often psychedelic and include symptoms like...
Psychedelic treatment: New psilocybin mushroom protocol

Psychedelic Capitalism and Other Myths: Is the Joke On Us?

by EmpathiCSubstanceS | Nov 8, 2021 | Addiction, Anxiety, Cannabis Marijuana, LSD, Psychotropics, San Pedro Mescaline

Is psychedelic capitalism a myth? The week I am writing this, author and psychedelic philanthropist Tim Ferriss poised a very direct question (via Twitter) to the public and various leaders in the psychedelic community, including Michael Pollan, Rick Doblin, and Robin...
Psychedelic treatment: New psilocybin mushroom protocol

What Is Transpersonal Psychology and How Does It Relate to Psychedelics?

by EmpathiCSubstanceS | Nov 7, 2021 | Addiction, Alcoholism, CBC, Chronic Pain, Cluster Headaches, Depression, Iboga, Kambo

Defining transpersonal psychology, exploring its history, and examining how it relates to psychedelic experiences. Transpersonal psychology, the branch of psychology that concerns itself with the study of spiritual experience and expanded states of consciousness, has...
« Older Entries
Next Entries »

IMPORTANT NOTICE:

This community is being designed as a secure space. It is not a place to seek, encourage, or participate in the procurement of controlled substances. Do not bring, buy, sell, transfer, or arrive on any illegal substances, or swap information on how to buy them. Attendees and/or members of this community who violate these basic house rules will be removed from the community and will not be allowed to attend future events.

Psychedelic Research

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences

Aug 17, 2022

High doses of both drugs produced similar increases in participant ratings of peak overall drug effect strength, with similar times to maximal effect and time-course. Psilocybin produced orderly dose-related increases on most participant-rated subjective measures...

Long-term follow-up of psilocybin-facilitated smoking cessation

Aug 17, 2022

All 15 participants completed a 12-month follow-up, and 12 (80%) returned for a long-term (≥16 months) follow-up, with a mean interval of 30 months (range = 16-57 months) between target-quit date (i.e., first psilocybin session) and long-term follow-up. At 12-month...

Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors

Aug 17, 2022

Outcomes at 6 months included rates of spiritual practice and persisting effects of psilocybin. Compared with low-dose, high-dose psilocybin produced greater acute and persisting effects. At 6 months, compared with LD-SS, both high-dose groups showed large significant...

Psychedelic Medicine

Are you ready to change your mind?

Jul 21, 2022

For decades, psychedelics have evoked a freewheeling past, calling to mind images of hippie counterculture and swirly neon patterns. Recently, however, psychedelics have become synonymous with serious, forward-looking science. Researchers at renowned institutions are...

How To Change Your Mind

Jul 21, 2022

Based on the book about psychedelic therapy, a new Netflix docu-series prompted another writer to reach out to Pollan — and dig into his own experiences.In late 2012, the best-selling author and journalist Michael Pollan (“The Omnivore’s Dilemma”) was at a dinner...

How to have a safe psychedelic Journey?

Jul 11, 2022

Remember that psychedelic substances are illegal in most jurisdictions. If you have physical or mental health issues, speak to a mental health professional before experimenting with psychedelics. Ensure you are in a physically safe, controlled environment. Always...

Which Are Natural Psychedelics?

Jul 5, 2022

What are the most common natural psychedelics? The natural world is full of psychedelic and other psychoactive substances. In fact, most synthetic psychedelics are derived or inspired by naturally-occurring substances. Many natural psychedelics are considered...

What are the benefits of consuming psilocybin magic mushrooms?

Jul 2, 2022

There are many benefits to consuming psilocybin magic mushrooms, and they have been used in many cultures around the world for thousands of years. Studies have shown “a single dose of psilocybin produced substantial and enduring decreases in depressed mood and anxiety...

© 2025| All Rights Reserved, EntheoMedicine Community
  • Follow
  • Follow
  • Follow
  • Follow